Once a neglected biological phenomenon, condensates are attracting interest from small companies and large pharmas.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle
Retrovirology Open Access 07 April 2023
-
Direct digital sensing of protein biomarkers in solution
Nature Communications Open Access 06 February 2023
-
Biomolecular condensate phase diagrams with a combinatorial microdroplet platform
Nature Communications Open Access 21 December 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dolgin, E. Drug startups coalesce around condensates. Nat Biotechnol 39, 123–125 (2021). https://doi.org/10.1038/s41587-021-00828-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-021-00828-4
This article is cited by
-
Biomolecular condensates: insights into early and late steps of the HIV-1 replication cycle
Retrovirology (2023)
-
Direct digital sensing of protein biomarkers in solution
Nature Communications (2023)
-
Biomolecular condensate phase diagrams with a combinatorial microdroplet platform
Nature Communications (2022)
-
Potential participation of CTRP6, a complement regulator, in the pathology of age related macular degeneration
Japanese Journal of Ophthalmology (2022)
-
Capillary flow experiments for thermodynamic and kinetic characterization of protein liquid-liquid phase separation
Nature Communications (2021)